This week on Pharm5:

• Detailing Eli Lilly’s insulin pricing


• RSV vaccines on the horizon


• XDR shigellosis health advisory


• OTC Flu+COVID test


• ASHP Match Rankings due 11:59 PM

Connect with us!

• Listen to our podcast: Pharm5


• Follow us on Twitter: @LizHearnPharmD

References:

1. Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month. Eli Lilly and Company. http://bit.ly/3ZQXVcf.  Published March 1, 2023. Accessed March 2, 2023.


2. Christensen J, Klein B. Eli Lilly to cut insulin prices, cap costs at $35 for many people with diabetes. CNN. http://bit.ly/3IHmyAY.  Published March 1, 2023. Accessed March 2, 2023.


3. Jewett C. F.D.A. panel recommends 2 R.S.V. vaccines for older adults. The New York Times. http://bit.ly/3SETqPv. Published March 1, 2023. Accessed March 2, 2023.


4. FDA advisers recommend World's first RSV vaccines, from Pfizer and GSK. NBCNews.com. http://bit.ly/3kNJsP7. Published March 1, 2023. Accessed March 2, 2023.


5. FDA authorizes first over-the-counter at-home test to detect both influenza and COVID-19 viruses. U.S. Food and Drug Administration. http://bit.ly/3ZB3FXf. Published February 24, 2023. Accessed March 2, 2023.


6. Increase in Extensively Drug-Resistant Shigellosis in the United States. Centers for Disease Control and Prevention. http://bit.ly/3ZBeRD5. Published February 24, 2023. Accessed March 2, 2023.


7. Charles H, Prochazka M, Thorley K, et al. Outbreak of sexually transmitted, extensively drug-resistant Shigella Sonnei in the UK, 2021–22: A descriptive epidemiological study. The Lancet Infectious Diseases. 2022;22(10):1503-1510. doi:10.1016/s1473-3099(22)00370-x


8. Schedule of Dates - The 2023 ASHP Match. ASHP Match | Schedule. https://bit.ly/3I8MJA7.  Published January 19, 2023. Accessed March 2, 2023.